Background Accumulating literature has shown the predictive values of inflammation and
nutrition-based biomarkers in the prognosis of oesophageal cancer but with inconsistent …

Immunotherapy plays an increasingly important role in the treatment of most malignant
tumors, and CD8+ T cells are the most important antitumor effector cells in the process of …

Background Previous studies have confirmed that systemic immune-inflammatory index (SII)
and prognostic nutritional index (PNI) can predict the prognosis and chemotherapy efficacy …

Objective Prognostic nutritional index (PNI), calculated as serum albumin (ALB)(g/L)+ 5×
total lymphocyte count (109/L), is initially used to evaluate nutritional status in patients …

Abstract Lessons Learned Radiotherapy plus anti–PD-1 antibody as first-line therapy is safe
and feasible in locally advanced esophageal squamous cell carcinoma (ESCC). Tumor …

Immunosuppressive molecules are extremely valuable prognostic biomarkers across
different cancer types. However, the diversity of different immunosuppressive molecules …

Multidisciplinary treatment for esophageal cancer leads to nutritional and inflammatory
changes. Recent studies showed that nutritional and inflammatory changes during …

Background Inflammation and nutrition and depression are interrelated, and both are related
to changes in mortality rates. We investigated the association of nutritional and inflammation …

Simple Summary The aim of this review was to describe the rationale for immunotherapy in
different stages of esophageal cancer (EC) treatment, with a particular accent on curative …

Background Prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), platelet-
to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) are the most …